STAAR Surgical Co. closed an underwritten public offering of 1,999,850 common shares priced at $39 apiece, raising gross proceeds of about $78 million.

The shares sold include the full exercise of the underwriter's option to buy up to an additional 260,850 common shares in the offering.

Monrovia, Calif.-based STAAR Surgical develops and manufactures implantable lenses and companion delivery systems for the eye.

Canaccord Genuity acted as the sole book-running manager for the transaction.